Evaluating current implantable cardioverter defibrillator implantation procedures: can common complications be minimised?

Expert Review of Cardiovascular Therapy
Liesbeth TimmersLuc Jordaens

Abstract

The implantable cardioverter-defibrillator (ICD) is the cornerstone of treatment and prevention of malignant ventricular arrhythmias. Despite 30 years of experience, implantation of ICDs carries a risk of complications both during the procedure and long-term follow-up. Operator and procedure related factors may contribute to this risk. Furthermore, access, pocket, device and lead related problems occur, on top of problems related to arrhythmias and the patient themselves. Infection is the most feared complication, and its incidence seems to rise. Factors leading to complications are assessed, as well as measures to reduce these complications, including antibiotics and subcutaneous devices. Four patient categories with an increased risk are identified: the elderly with atrial fibrillation, diabetes or renal failure; the pediatric patient with or without congenital heart disease, the young patient with specific inherited diseases, and all those who undergo replacement, upgrade or concomitant lead extraction.

References

Jan 1, 1988·Acta Clinica Belgica·L JordaensH Kulbertus
Aug 7, 1980·The New England Journal of Medicine·M MirowskiM L Weisfeldt
May 1, 1995·Pacing and Clinical Electrophysiology : PACE·M RoelkeJ N Ruskin
Jul 1, 1993·Pacing and Clinical Electrophysiology : PACE·L JordaensY van Belleghem
Mar 21, 1998·Pacing and Clinical Electrophysiology : PACE·D AntonelliS Furman
Jun 3, 1999·Pacing and Clinical Electrophysiology : PACE·V Parsonnet, M Roelke
Jan 21, 2000·Pacing and Clinical Electrophysiology : PACE·F MeraA R Léon
Aug 14, 2003·Pacing and Clinical Electrophysiology : PACE·Rainer GradausUNKNOWN German EURID Registry
Jun 21, 2005·Journal of the American College of Cardiology·Robert G Hauser
Jan 13, 2006·Journal of Cardiovascular Electrophysiology·Jacques Billette, Michel Lavallée
Feb 24, 2006·Pacing and Clinical Electrophysiology : PACE·Heather BloomJonathan Langberg
Mar 15, 2006·Journal of Cardiovascular Electrophysiology·Maximo Rivero-AyerzaLuc J Jordaens
Aug 9, 2006·The American Journal of Cardiology·Ilan GoldenbergUNKNOWN Multicenter Automatic Defibrillator Implantation Trial-II Investigators
Jan 5, 2007·Pacing and Clinical Electrophysiology : PACE·Thomas KriebelThomas Paul
Aug 3, 2007·Pacing and Clinical Electrophysiology : PACE·David J FoxAdam P Fitzpatrick
Dec 12, 2007·Pacing and Clinical Electrophysiology : PACE·Ernest W Lau
Jan 22, 2008·Journal of the American College of Cardiology·Ilan GoldenbergUNKNOWN MADIT-II Investigators
Mar 28, 2009·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·H H F RemmeltsP M Ellerbroek
Apr 23, 2009·JAMA : the Journal of the American Medical Association·Jeptha P CurtisHarlan M Krumholz
Oct 29, 2009·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Thomas KleemannKarlheinz Seidl
Dec 23, 2009·Pacing and Clinical Electrophysiology : PACE·Jogien H M HeerscheA Derk Jan ten Harkel
Jan 8, 2010·The New England Journal of Medicine·Rabih O DarouicheDavid H Berger
May 14, 2010·The New England Journal of Medicine·Gust H BardyAndrew A Grace
Aug 21, 2010·Pacing and Clinical Electrophysiology : PACE·Karen A McLeod, Andrew McLean
Oct 15, 2010·Pacing and Clinical Electrophysiology : PACE·Heather L BloomUNKNOWN COoperative Multicenter study Monitoring a CIED ANtimicrobial Device Investigators
Feb 18, 2011·Circulation. Arrhythmia and Electrophysiology·Andrew D KrahnUNKNOWN Ontario ICD Database Investigators
Mar 4, 2011·The Journal of Hospital Infection·S M McHughH Humphreys
Jul 21, 2011·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·T SmithL Jordaens
Aug 27, 2011·Journal of the American College of Cardiology·Arnold J GreensponSteven M Kurtz
Dec 1, 2011·Pacing and Clinical Electrophysiology : PACE·Charles K FrancisSteven Daniels

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.